191 related articles for article (PubMed ID: 37189819)
1. Design of Chitosan-Coated, Quercetin-Loaded PLGA Nanoparticles for Enhanced PSMA-Specific Activity on LnCap Prostate Cancer Cells.
Essa D; Kondiah PPD; Kumar P; Choonara YE
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189819
[TBL] [Abstract][Full Text] [Related]
2. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
4. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
[TBL] [Abstract][Full Text] [Related]
5. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
6. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Sabzini M; Pourmadadi M; Yazdian F; Khadiv-Parsi P; Rashedi H
Int J Biol Macromol; 2023 Jan; 226():159-171. PubMed ID: 36435458
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
Meher N; Seo K; Wang S; Bidkar AP; Fogarty M; Dhrona S; Huang X; Tang R; Blaha C; Evans MJ; Raleigh DR; Jun YW; VanBrocklin HF; Desai TA; Wilson DM; Ozawa T; Flavell RR
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54739-54752. PubMed ID: 34752058
[TBL] [Abstract][Full Text] [Related]
8. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
9. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
[TBL] [Abstract][Full Text] [Related]
10. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
Ma G; Severic M; Barker M; Pereira S; Ruiz A; Cheung CCL; Al-Jamal WT
Acta Biomater; 2021 Oct; 134():559-575. PubMed ID: 34274531
[TBL] [Abstract][Full Text] [Related]
11. Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer.
Yari H; Nkepang G; Awasthi V
Materials (Basel); 2019 Mar; 12(5):. PubMed ID: 30841602
[TBL] [Abstract][Full Text] [Related]
12. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y
Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032
[TBL] [Abstract][Full Text] [Related]
13. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
14. Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.
Evans JC; Malhotra M; Guo J; O'Shea JP; Hanrahan K; O'Neill A; Landry WD; Griffin BT; Darcy R; Watson RW; O'Driscoll CM
Nanomedicine; 2016 Nov; 12(8):2341-2351. PubMed ID: 27389146
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation.
Jana D; Han Z; Huang X; Wadhwa A; Raveendran A; Ebeid K; Meher N; Flavell RR; Desai T
ACS Nano; 2024 Jun; ():. PubMed ID: 38907991
[TBL] [Abstract][Full Text] [Related]
16. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
18. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
19. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line.
Abd-Rabou AA; Ahmed HH
Adv Med Sci; 2017 Sep; 62(2):357-367. PubMed ID: 28521254
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines.
Tousi MS; Sepehri H; Khoee S; Farimani MM; Delphi L; Mansourizadeh F
J Pharm Anal; 2021 Feb; 11(1):108-121. PubMed ID: 33717617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
